Clinical Trial Update: Azathioprine in MOGAD [Phase 3]

View source ↗

Summary

Ongoing Phase 3 clinical trial evaluating azathioprine for MOG antibody-associated disease (MOGAD), sponsored by Hospices Civils de Lyon, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mog Antibody-associated Disease

Drugs mentioned

• Azathioprine (azathioprine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Central Nervous System Inflammation, MOG-IgG Associated Disease | Phase 3 | Status: RECRUITING